KISS1R Antagonism as a Promising Anti-Cancer Approach An Overview on Function, Molecular Mechanisms and Therapeutic Potential

Herein, we explore the Kisspeptin 1 Receptor KISS1R as a potential therapeutic target for the restoration of drug sensitivity in Triple Negative Breast Cancer TNBC clinical settings.

Authors

Publication Details

Journal
Journal on oncology
Published
2024-09-23
DOI
https://doi.org/10.52768/2692-563x/1147
Primary Topic
Enzyme function and inhibition
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

KISS1R Antagonism as a Promising Anti-Cancer Approach An Overview on Function, Molecular Mechanisms and Therapeutic Potential

John W. Scanlon
Journal on oncology
Enzyme function and inhibition
article

KISS1R Antagonism as a Promising Anti-Cancer Approach An Overview on Function, Molecular Mechanisms and Therapeutic Potential

John W. Scanlon
article en

Abstract

Herein, we explore the Kisspeptin 1 Receptor KISS1R as a potential therapeutic target for the restoration of drug sensitivity in Triple Negative Breast Cancer TNBC clinical settings.

Journal on oncologyVol. 4(2)
Openalex Percentile: Top 78%
Enzyme function and inhibition
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

KISS1R Antagonism as a Promising Anti-Cancer Approach An Overview on Function, Molecular Mechanisms and Therapeutic Potential — John W. Scanlon · Journal on oncology (2024) | TGRS Research Map | TGRS